The pharmaceutical companies Pfizer and Valneva say their vaccine shows promising results, as they seek Food and Drug ...

Pfizer is working to get approval on a new vaccine that could protect people against Lyme disease. WBZ-TV's Mike Sullivan reports.

Lyme disease infects hundreds of thousands of people each year and now scientists may be on the verge of a breakthrough with ...

I didn’t get better on his steady dose of antibiotics, the constant pain didn’t go away — while the advice to go off ...

Earlier this week, pharmaceutical company Pfizer and its partner Valneva announced that an experimental Lyme disease vaccine ...

Pfizer's shot fell short of its initial trial goal, but with nearly half a million Americans infected each year, the company ...

The first human Lyme disease vaccine was 73% effective against the tick-borne illness, says Pfizer. They still plan to seek ...

An experimental vaccine for Lyme disease is broadly effective, pharmaceutical companies Pfizer and Valneva announced Monday, ...

If approved by regulators, it could become the only Lyme disease vaccine available for people — although it would not be the ...

Dr. Todd Ellerin of South Shore Health discusses the experimental Lyme disease vaccine that will go in front of the FDA.

If approved by regulators, it would be the only vaccine for humans against Lyme disease.

The drugmaker is seeking regulatory review for the first new shot to combat the disease in decades.